Loading organizations...
§ Private Profile · Gaithersburg, MD, USA
Biopharmaceutical company developing mRNA therapeutics and vaccines.
RNAimmune has raised $12.3M across 2 funding rounds.
RNAimmune has raised $12.3M in total across 2 funding rounds.
RNAimmune has raised $12.3M across 2 funding rounds. Most recently, it raised $10.0M Seed in April 2021.
| Date | Round | Lead Investors | Other Investors | Status |
|---|---|---|---|---|
| Apr 22, 2021 | $10M Seed | Hong Kong Hongrun, Smooth River | High Forest Investment, Terra Magnum Capital Partners, Walvax Biotechnology | Announced |
| Aug 24, 2020 | $2.4M Seed | Terra Magnum Capital Partners | — | Announced |
RNAimmune has raised $12.3M in total across 2 funding rounds.
RNAimmune's investors include Hong Kong Hongrun, Smooth River, High Forest Investment, Terra Magnum Capital Partners, Walvax Biotechnology.